LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Optical Immunosensors Improve POC Diagnostics

By LabMedica International staff writers
Posted on 12 Feb 2009
Optical immunosensors are precise, fast, easy-to-use systems for point-of-care diagnostics in hospitals, physicians' practices, or in homecare.

Scientists have been working on the development of selective monoclonal antibodies (mAbs) for certain target structures and for use in immunosensors for some time. They have now succeeded in developing mAbs for procalcitonin (PCT), a specific marker for microbial infections and sepsis. Determination of PCT concentrations in serum is of significance, both for the early diagnosis of microbial infections and for controlling antibiotic treatment.

Using surface plasmon resonance (SPR) technology, biomolecular interactions between analytes in solution and antibodies immobilized on the surface of the sensor can be detected quickly, with high sensitivity, and without the otherwise required labeling of reaction partners.

SPR-based immunosensors are of interest for the detection of ligands in biomedical applications, in food, or in the environment. Dr. M. F. Gouzy, from the Institute of Ecological Chemistry, Helmholtz Center Munich (Munich, Germany), and colleagues have succeeded in developing a reusable SPR-based immunosensor, which is described in the February 2009 issue of the journal Biosensors and Bioelectronics.

Newly developed procalcitonin (PCT) antibodies from the rat were used successfully in the enzyme-linked immunosorbant assay (ELISA) in testing human serum for PCT. Some of these mAbs were marked with fluorescent dye and are presently being integrated by scientific groups in Germany and Italy into new optical immunosensors.

Related Links:
Helmholtz Center



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit

Latest Immunology News

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
12 Feb 2009  |   Immunology

Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
12 Feb 2009  |   Immunology

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions
12 Feb 2009  |   Immunology